INmune Bio, Inc. (INMB)
1.21
-0.02
(-1.63%)
USD |
NASDAQ |
Apr 02, 16:00
1.215
0.00 (0.00%)
After-Hours: 20:00
INmune Bio EPS Diluted (Quarterly) : -0.198 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AngioDynamics, Inc. | -0.1944 |
| Omeros Corp. | 0.9771 |
| Precipio, Inc. | 0.2954 |
| PDS Biotechnology Corp. | -0.1405 |
| Sangamo Therapeutics, Inc. | -0.1108 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.264M |
| Total Expenses (Quarterly) | 5.264M |
| Enterprise Value | 8.451M |
| Earnings Yield | -159.0% |
| Normalized Earnings Yield | -119.32 |